Cargando…
Application of CRISPR-Cas9 gene editing technology in basic research, diagnosis and treatment of colon cancer
Colon cancer is the fourth leading cause of cancer death worldwide, and its progression is accompanied by a complex array of genetic variations. CRISPR/Cas9 can identify new drug-resistant or sensitive mutations in colon cancer, and can use gene editing technology to develop new therapeutic targets...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10067930/ https://www.ncbi.nlm.nih.gov/pubmed/37020597 http://dx.doi.org/10.3389/fendo.2023.1148412 |
_version_ | 1785018580853587968 |
---|---|
author | Meng, Hui Nan, Manman Li, Yizhen Ding, Yi Yin, Yuhui Zhang, Mingzhi |
author_facet | Meng, Hui Nan, Manman Li, Yizhen Ding, Yi Yin, Yuhui Zhang, Mingzhi |
author_sort | Meng, Hui |
collection | PubMed |
description | Colon cancer is the fourth leading cause of cancer death worldwide, and its progression is accompanied by a complex array of genetic variations. CRISPR/Cas9 can identify new drug-resistant or sensitive mutations in colon cancer, and can use gene editing technology to develop new therapeutic targets and provide personalized treatments, thereby significantly improving the treatment of colon cancer patients. CRISPR/Cas9 systems are driving advances in biotechnology. RNA-directed Cas enzymes have accelerated the pace of basic research and led to clinical breakthroughs. This article reviews the rapid development of CRISPR/Cas in colon cancer, from gene editing to transcription regulation, gene knockout, genome-wide CRISPR tools, therapeutic targets, stem cell genomics, immunotherapy, metabolism-related genes and inflammatory bowel disease. In addition, the limitations and future development of CRISPR/Cas9 in colon cancer studies are reviewed. In conclusion, this article reviews the application of CRISPR-Cas9 gene editing technology in basic research, diagnosis and treatment of colon cancer. |
format | Online Article Text |
id | pubmed-10067930 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-100679302023-04-04 Application of CRISPR-Cas9 gene editing technology in basic research, diagnosis and treatment of colon cancer Meng, Hui Nan, Manman Li, Yizhen Ding, Yi Yin, Yuhui Zhang, Mingzhi Front Endocrinol (Lausanne) Endocrinology Colon cancer is the fourth leading cause of cancer death worldwide, and its progression is accompanied by a complex array of genetic variations. CRISPR/Cas9 can identify new drug-resistant or sensitive mutations in colon cancer, and can use gene editing technology to develop new therapeutic targets and provide personalized treatments, thereby significantly improving the treatment of colon cancer patients. CRISPR/Cas9 systems are driving advances in biotechnology. RNA-directed Cas enzymes have accelerated the pace of basic research and led to clinical breakthroughs. This article reviews the rapid development of CRISPR/Cas in colon cancer, from gene editing to transcription regulation, gene knockout, genome-wide CRISPR tools, therapeutic targets, stem cell genomics, immunotherapy, metabolism-related genes and inflammatory bowel disease. In addition, the limitations and future development of CRISPR/Cas9 in colon cancer studies are reviewed. In conclusion, this article reviews the application of CRISPR-Cas9 gene editing technology in basic research, diagnosis and treatment of colon cancer. Frontiers Media S.A. 2023-03-20 /pmc/articles/PMC10067930/ /pubmed/37020597 http://dx.doi.org/10.3389/fendo.2023.1148412 Text en Copyright © 2023 Meng, Nan, Li, Ding, Yin and Zhang https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Endocrinology Meng, Hui Nan, Manman Li, Yizhen Ding, Yi Yin, Yuhui Zhang, Mingzhi Application of CRISPR-Cas9 gene editing technology in basic research, diagnosis and treatment of colon cancer |
title | Application of CRISPR-Cas9 gene editing technology in basic research, diagnosis and treatment of colon cancer |
title_full | Application of CRISPR-Cas9 gene editing technology in basic research, diagnosis and treatment of colon cancer |
title_fullStr | Application of CRISPR-Cas9 gene editing technology in basic research, diagnosis and treatment of colon cancer |
title_full_unstemmed | Application of CRISPR-Cas9 gene editing technology in basic research, diagnosis and treatment of colon cancer |
title_short | Application of CRISPR-Cas9 gene editing technology in basic research, diagnosis and treatment of colon cancer |
title_sort | application of crispr-cas9 gene editing technology in basic research, diagnosis and treatment of colon cancer |
topic | Endocrinology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10067930/ https://www.ncbi.nlm.nih.gov/pubmed/37020597 http://dx.doi.org/10.3389/fendo.2023.1148412 |
work_keys_str_mv | AT menghui applicationofcrisprcas9geneeditingtechnologyinbasicresearchdiagnosisandtreatmentofcoloncancer AT nanmanman applicationofcrisprcas9geneeditingtechnologyinbasicresearchdiagnosisandtreatmentofcoloncancer AT liyizhen applicationofcrisprcas9geneeditingtechnologyinbasicresearchdiagnosisandtreatmentofcoloncancer AT dingyi applicationofcrisprcas9geneeditingtechnologyinbasicresearchdiagnosisandtreatmentofcoloncancer AT yinyuhui applicationofcrisprcas9geneeditingtechnologyinbasicresearchdiagnosisandtreatmentofcoloncancer AT zhangmingzhi applicationofcrisprcas9geneeditingtechnologyinbasicresearchdiagnosisandtreatmentofcoloncancer |